Xcout IntelSign inSubscribe

Molecule.one competitors & alternatives

BiotechnologyPoland

The 12 closest competitors and alternatives to Molecule.one among biotechnology companies — ranked by similarity to what Molecule.one actually does, not by market-cap band.

12Competitors listed

Subscribe to see Molecule.one’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Molecule.one

Molecule.one is a chemistry artificial intelligence company that develops autonomous discovery software for chemical research. Headquartered in Portola Valley, California, the company operates research and technical facilities to accelerate laboratory workflows.

Molecule.one at a glance

Molecule.one is a biotechnology company headquartered in Poland. It has raised at least $5.6M across the 2 funding rounds on record. Its most recent funding round, Pre-seed, raised $1M in July 2026. Xcout tracks 5 named people at Molecule.one, including Dr. Piotr Byrski (CEO and Co-Founder).

Molecule.one leadership

  • Dr. Piotr ByrskiCEO and Co-Founder
  • Piotr ByrskiCEO & CO-FOUNDER
  • Stanisław JastrzębskiCTO & CHIEF SCIENTIST & CO-FOUNDER
  • Pawel Wlodarczyk-PruszynskiENGINEERING FELLOW & CO-FOUNDER
  • Paulina WachDIRECTOR OF OPERATIONS & HEAD OF CHEMISTRY

Molecule.one funding rounds

At least $5.6M raised across the 2 rounds on record. Every round on record:

DateRoundAmountInvestors
Pre-seed$1M8 named
Seed$4.6M8 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 Molecule.one competitors

Ranked by semantic similarity — how close each company is to Molecule.one by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

METIS TECHBIO-P07666 · BiotechBeijing, China
64% matchPublic

Biotech

Metis TechBio Co., Ltd., founded in 2020 and headquartered in Beijing, China, (previously Hangzhou Jitai Pharmaceutical Technology Co., Ltd.) specializes in the advanced research and development of AI-powered nanomaterials. The company's core mission is to facilitate the delivery and application of active agents within carbon-based life forms, operating in both the Chinese Mainland and the United States. Central to its offerings is NanoForge, a comprehensive suite of interconnected technologies that includes a novel lipid library, foundational artificial intelligence models, METiSAIAgent, cutting-edge quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. Furthermore, Metis TechBio has developed specialized platforms like AiTEM, AiLNP, and AiRNA. These tools are crucial for simulating, predicting, and interpreting interactions at the nanoscale, thereby enabling the precise design, optimization, and validation of sophisticated nanomaterials and their associated payloads. The company provides its services through a three-tiered system: a foundational dry-wet data layer supported by integrated laboratory infrastructure, a model layer featuring METiS AI foundational models, and an application layer known as METiSAgentv. Metis TechBio primarily serves a diverse clientele, including pharmaceutical companies, biotechnology firms, and medical research institutions.

Market cap$1.9B
Employees5
METIS TECHBIO-P competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Molecule.one and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Molecule.oneand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →